- Home
- PLTR vs ABT Comparison
PLTR vs ABT Comparison
Compare PLTR & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLTR | ABT |
|---|---|---|
| Founded | 2003 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.9B | 173.2B |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | PLTR | ABT |
|---|---|---|
| Price | $200.34 | $104.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 32 | 28 |
| Target Price | ★ $205.27 | $120.72 |
| AVG Volume (30 Days) | ★ 17.8M | 5.4M |
| Earning Date | 11-02-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 2.45% |
| EPS Growth | ★ 231.58 | N/A |
| EPS | ★ 0.75 | 0.61 |
| Revenue | $4,475,446,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $83.56 | $13.24 |
| Revenue Next Year | $49.82 | $8.62 |
| P/E Ratio | $267.51 | ★ $168.98 |
| Revenue Growth | ★ 56.18 | 5.67 |
| 52 Week Low | $106.37 | $81.97 |
| 52 Week High | $212.94 | $132.03 |
Technical Indicators
Market Signals| Indicator | PLTR | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 62.17 | 58.67 |
| Support Level | $124.09 | $100.60 |
| Resistance Level | N/A | $110.95 |
| Average True Range (ATR) | 5.87 | 2.05 |
| MACD | 0.56 | 0.82 |
| Stochastic Oscillator | 55.21 | 92.47 |
Price Performance
Historical ComparisonAbout PLTR Palantir Technologies Inc.
Palantir is an artificial intelligence, analytics, and automated decision-making company that leverages data to drive efficiency across its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The company was founded in 2003 and went public in 2020.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.